03.08.25 -- Outsourced Pharma Best Of February

CDMOs seem determined to do two things more strategically and with a greater focus: build on what they do best (instead of spreading across services); and differentiate themselves by a devotion to customer service. Part two from JPM25.

Conversations with seasoned biopharma executives reveal surprising insights on CDMO selection. Chief Editor Louis Garguilo explores key takeaways, including preparation, responsibilities, and CDMO trends.

API payloads used in antibody-drug conjugates are some of the most potent substances in biopharma, so it's important to protect workers who handle them.

Choosing the right packaging partner for your probiotic may be the most crucial step to ensuring your product is safe and potent when it reaches the consumer.

This study introduces methods for quantifying AAV9 capsid titer and host-cell-derived impurities, offering a robust, adaptable solution for enhancing rAAV batch release testing under GMP conditions.

Learn the fundamentals of developing a continuous chromatography process with Simulated Moving Bed (SMB) technology for small molecules, from gram-scale to multi-ton commercial production.